ENI, San Donato Milanese, Italy.
Queensland Centre for Mental Health Research, The University of Queensland, Brisbane, Queensland, Australia.
BMJ Ment Health. 2023 Oct;26(1). doi: 10.1136/bmjment-2023-300870.
People with severe mental illness (SMI) have a higher prevalence of several chronic physical health conditions, and the prevalence of physical multimorbidity is expected to rise. The aim of this study was to assess the strength of the association between SMI and physical multimorbidity.
We systematically searched PubMed/Medline, Scopus, Embase, Web of Science, PsycINFO and the behavioural sciences collection databases, from inception to 31 January 2023, for studies that investigated the association between SMI and physical multimorbidity. Humans of any age either clinically diagnosed and/or currently receiving treatment for SMI, specified as schizophrenia (and related psychotic disorders), bipolar disorder and psychotic depression, were eligible. Data from studies selected for inclusion were converted into ORs, with a subsequent meta-analysis conducted.
We included 19 studies with a total of 194 123 patients with SMI with different diagnoses and drawn from the general population. The pooled OR for physical multimorbidity in people with versus without SMI was 1.84 (95% CI 1.33 to 2.54), with the analysis indicating a high level of heterogeneity (98.38%). The other 15 studies included in the systematic review for which it was not possible to conduct a meta-analysis showed strong associations between SMI and physical multimorbidity.
The current evidence highlights the link between SMI and physical multimorbidity. A multidisciplinary approach is now urgent to develop the best models of services tailored to patients with SMI with physical multimorbidities to improve physical, mental and social outcomes. CRD42023395165.
患有严重精神疾病 (SMI) 的人有多种慢性身体健康状况的更高患病率,预计身体多病共存的患病率将会上升。本研究的目的是评估 SMI 与身体多病共存之间的关联强度。
我们系统地检索了 PubMed/Medline、Scopus、Embase、Web of Science、PsycINFO 和行为科学收藏数据库,从创建到 2023 年 1 月 31 日,以调查 SMI 和身体多病共存之间的关联的研究。任何年龄的人类,无论是临床诊断和/或目前正在接受 SMI 治疗的,指定为精神分裂症(和相关的精神病性障碍)、双相情感障碍和精神病性抑郁症,都符合条件。从入选的研究中提取数据并转换为 OR,随后进行荟萃分析。
我们纳入了 19 项研究,共纳入了 194123 名患有不同诊断的 SMI 患者,这些患者来自普通人群。患有 SMI 的人与没有 SMI 的人相比,身体多病共存的 OR 为 1.84(95%CI 1.33 至 2.54),分析表明存在高度异质性(98.38%)。另外 15 项研究虽然纳入了系统评价,但无法进行荟萃分析,这些研究都表明 SMI 与身体多病共存之间存在很强的关联。
目前的证据强调了 SMI 和身体多病共存之间的联系。现在迫切需要采取多学科方法,制定最适合患有身体多病共存的 SMI 患者的服务模式,以改善身体、心理和社会结果。CRD42023395165。